GGrantIndex
Sort

64,565 grants matching drug discovery

Detecting synergistic effects of pharmacological and non-pharmacological interventions for AD/ADRD

$772,030
Rui Zhang · University Of Minnesota · R01 · FY2024 · AG

BKV and JCV vaccine development

$771,566
Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

The Genetic Basis of Opioid Dependence Vulnerablility in a Rodent Model

$771,565
Peter W Kalivas · Medical University Of South Carolina · U01 · FY2019 · DA

Finding combinatorial drug repositioning therapy for Alzheimer's disease and related dementias

$771,560
Xiaoqian Jiang · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · AG

Finding combinatorial drug repositioning therapy for Alzheimer's disease and related dementias

$771,560
Xiaoqian Jiang · University Of Texas Hlth Sci Ctr Houston · R01 · FY2024 · AG

Finding combinatorial drug repositioning therapy for Alzheimer's disease and related dementias

$771,560
Xiaoqian Jiang · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · AG

Combatting natural resistance and persistence in non-TB mycobacterial disease

$771,560
Thomas Dick · Rbhs-New Jersey Medical School · R01 · FY2018 · AI

The Plasmodial Surface Anion Channel And Malaria Parasite Nutrient Acquisition

$771,488
Sanjay A Desai · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI

Disease-Specific Integrated Microphysiological Human Tissue Models

$771,487
Kevin E Healy · University Of California Berkeley · UH2 · FY2013 · TR

Bay Area Cancer Target Discovery and Development Network

$771,465
Michael T McManus · University Of California, San Francisco · U01 · FY2016 · CA

Intergenerational Transmission of Neglect and Abuse

$771,450
Cathy Spatz Widom · John Jay College Of Criminal Justice · R01 · FY2009 · HD

Modulation of the Innate Immune Response by Fisetin Derivatives for the Treatment of AD

$771,449
Pamela Anne Maher · Virogenics, Inc. · R42 · FY2016 · AI

Endophenotype Network-based Approaches to Prediction and Population-based Validation of in Silico Drug Repurposing for Alzheimer’s Disease

$771,366
Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · AG

Peptide Biomarkers for Alzheimer Disease

$771,363
Jing Zhang · University Of Washington · R01 · FY2017 · AG

Targeting Mutant KRAS for Cancer Therapy

$771,228
Said M Sebti · Virginia Commonwealth University · R35 · FY2022 · CA

GUARD: A global unbiased antimicrobial discovery platform

$771,172
Arul Jayaraman · Texas Engineering Experiment Station · R01 · FY2023 · AI

Scalable, all-optical assays of synaptic function and plasticity

$771,167
Graham Thomas Dempsey · Q-State Biosciences, Inc. · R44 · FY2020 · MH

A Community Zebrafish Resource for Modeling GWAS Biology

$771,156
Wolfram Goessling · Brigham And Women'S Hospital · R24 · FY2018 · OD

Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care - Resubmission 01

$771,045
Peter Hugh O'Donnell · University Of Chicago · R01 · FY2018 · HG

Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy

$770,953
Edmund Vincent Capparelli · University Of California, San Diego · U54 · FY2011 · HD

A Community Zebrafish Resource for Modeling GWAS Biology

$770,889
Wolfram Goessling · Brigham And Women'S Hospital · R24 · FY2021 · OD

A Community Zebrafish Resource for Modeling GWAS Biology

$770,889
Wolfram Goessling · Brigham And Women'S Hospital · R24 · FY2019 · OD

A Community Zebrafish Resource for Modeling GWAS Biology

$770,889
Wolfram Goessling · Brigham And Women'S Hospital · R24 · FY2020 · OD

Gene discovery in multi-ethnic late-onset Alzheimer's disease families

$770,831
Badri N Vardarajan · Columbia University Health Sciences · U01 · FY2021 · AG

Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates

$770,793
Michael R Weed · Virscio, Inc. · R44 · FY2021 · AG